ScreenerHero
ALGENgenOway Société anonyme
EPA · FR · Healthcare · Biotechnology · genoway.com
2.460EUR+2.07%Mkt Cap: 32.99M $P/E: 24.60

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as k…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap32.99M $
Enterprise Value—
Revenue (TTM)31.09M $
Gross Profit11.14M $
Net Income (TTM)1.01M $
Revenue/Share—
Last Price2.460 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004053510
Valuation
P/E (Trailing)24.60
P/E (Forward)16.33
PEG—
EV/EBITDA—
EV/Revenue—
P/S1.06
P/B1.34
EPS (TTM)0.10
EPS (Forward)0.15
52W Range
2.10033% of range3.200
52W High3.200 EUR
52W Low2.100 EUR
Profitability
Gross Margin48.90%
Oper. Margin8.43%
EBITDA Margin15.48%
Profit Margin4.43%
ROE3.71%
ROA2.05%
Growth
Revenue Growth10.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.55M $
CapEx (TTM)11.88M $
FCF Margin-40.67%
FCF Yield-38.32%
Net Debt7.30M $
Net Debt/EBITDA1.52
Balance Sheet
Debt/Equity0.55
Current Ratio3.14
Quick Ratio2.96
Book Value/Sh1.832 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.34M
Float—
Insiders31.39%
Institutions13.81%
Technical
SMA 502.431 (+1.2%)
SMA 2002.461 (-0.0%)
Beta0.37
S&P 52W Chg18.16%
Avg Vol (30d)11.21K
Avg Vol (10d)4.92K
Technical Indicators
RSI (14)43.0
MACD0.0029
MACD Signal0.0130
MACD Hist.-0.0101
BB Upper2.532 EUR
BB Middle2.474 EUR
BB Lower2.417 EUR
BB Width4.62%
ATR (14)0.0548 EUR
Vol Ratio (20d)0.35x